Concentra Group Holdings Parent (CON) Proxy Filing summary

Executive summary

• The annual meeting will be held virtually on April 30, 2026, with voting eligibility for shareholders of record as of March 5, 2026.

• Key proposals include electing three Class II directors, a non-binding advisory vote on executive compensation, and ratification of the external auditor.

• The Board recommends voting in favor of all proposals and emphasizes the importance of shareholder participation.

Voting matters and shareholder proposals

• Shareholders will vote on electing Vipin Gopal, William K. Newton, and Marc R. Watkins, MD as Class II directors for three-year terms.

• A non-binding advisory vote on executive compensation (say-on-pay) is included.

• Ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026 is proposed.

• Shareholder proposals for the 2027 meeting must be submitted by November 17, 2026, to be included in the proxy statement.

Board of directors and corporate governance

• The Board consists of seven members, with a majority deemed independent under NYSE standards.

• Board committees include Audit and Compliance, Human Capital and Compensation, Nominating, Governance and Sustainability, and Quality of Care and Patient Safety.

• The Board meets at least quarterly, and all directors attended all meetings in 2025.

• A Lead Director structure is in place to enhance independent oversight.

• Directors are expected to adhere to stock ownership guidelines and a code of conduct.